Search Ontology:
ChEBI
succinyl-Leu-Leu-Val-Tyr-7-amino-4-methylcoumarin
- Term ID
- CHEBI:52770
- Synonyms
-
- 4-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-3-(4-hydroxyphenyl)-1-[(4-methyl-2-oxochromen-7-yl)amino]-1-oxopropan-2-yl]amino]-3-methyl-1-oxobutan-2-yl] amino]-4-methyl-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-4-oxobutanoic acid
- N-(3-carboxypropanoyl)-L-leucyl-L-leucyl-L-valyl-N-(4-methyl-2-oxo-2H-chromen-7-yl)-L-tyrosinamide
- N-Succinyl-leu-leu-val-tyr-7-amido-4-methylcoumarin
- S6510_sigma
- Suc-leu-leu-val-tyr-7-amino-4-methylcoumarin
- Suc-Leu-Leu-Val-Tyr-AMC
- Suc-leu-leu-val-tyr-mca
- Suc-LLVY-AMC
- Suc-LLVY-mca
- Succinyl-leucyl-leucyl-valyl-tyrosyl-methylcoumarinamide
- Definition
- A tetrapeptide compound with a succinyl group at the N-terminal and a 7-amino-4-methylcoumarin group at the C-terminal.
- References
-
- Beilstein:6887904
- CAS:94367-21-2
- Ontology
- ChEBI ( EBI )
- Resources
- CTD
- is a type of
-
- has_role
-
Phenotype
Phenotype resulting from succinyl-Leu-Leu-Val-Tyr-7-amino-4-methylcoumarin
Phenotype where environments contain succinyl-Leu-Leu-Val-Tyr-7-amino-4-methylcoumarin
Phenotype modified by environments containing succinyl-Leu-Leu-Val-Tyr-7-amino-4-methylcoumarin
Human Disease Model